Chris Schott's questions to JOHNSON & JOHNSON (JNJ) leadership • Q3 2025
Question
Chris Schott inquired about Johnson & Johnson's perspective on emerging MFN agreements with the administration, particularly those focused on new Medicaid launches, and the company's overall approach to policy dynamics like MFN tariffs.
Answer
Chairman and CEO Joaquin Duato stated that Johnson & Johnson maintains an open dialogue with the administration, seeking common ground on priorities such as patient access to affordable innovation, preventing foreign entities from free-riding on U.S. innovation, maintaining U.S. life sciences leadership, and investing in domestic manufacturing. He expressed optimism for a positive outcome from these ongoing discussions.